Onset of analgesia by a topically administered flurbiprofen lozenge: a randomised controlled trial using the double stopwatch method

Abstract

Background:

The double stopwatch (DSW) method for determining the onset of analgesic activity has been implemented extensively by investigators studying orally administered drugs.

Objective:

The aim of this randomised, placebo-controlled trial was to use the DSW method to determine the time to onset of analgesia of a single dose of a topically administered non-steroidal anti-inflammatory drug, flurbiprofen 8.75 mg lozenge.

Methods:

Adults with acute sore throat (n = 122) were examined to confirm the presence of tonsillopharyngitis (Tonsillo-Pharyngitis Assessment) and sore throat pain of at least moderate intensity (≥6 on a 0–10 Sore Throat Scale). Lozenges containing flurbiprofen 8.75 mg or inert ingredients (identically flavoured) were administered under double-blind conditions in the clinic while patients assessed pain and pain relief over 3 hours. Onset of analgesia was determined using the DSW method and reported as the Kaplan–Meier median time to meaningful relief. The median time to first perceived relief was also documented.

Results:

About 78% of flurbiprofen-treated patients reported meaningful pain relief compared with 48% of placebo-treated patients (p < 0.01); median time to meaningful relief for flurbiprofen-treated patients was 43 minutes (placebo-treated patients were right-censored due to non-responsivity; p = 0.01). Median time to first perceived pain relief was 11 minutes for flurbiprofen-treated patients and 19 minutes for placebo-treated patients (p = 0.03). Flurbiprofen lozenge was well tolerated, with no serious adverse events occurring and no patient discontinuing due to an adverse event.

Conclusion:

These results indicate that the DSW method can be successfully applied to the evaluation of the onset of action of a locally administered analgesic in patients with acute sore throat, demonstrating that the onset of action (time to meaningful pain relief) of flurbiprofen lozenge was <45 minutes.

Keywords

Double stopwatch method topical analgesia onset of action flurbiprofen pharyngitis sore throat

Get full access to this article

View all access options for this article.

References

Brain

Leyva

Doyle

et al . Onset of analgesia and efficacy of ibuprofen sodium in postsurgical dental pain: a randomized, placebo-controlled study versus standard ibuprofen. Clin J Pain 2015; 31: 444–450.

Desjardins

Black

Balm

et al . Onset of analgesia: further validation of a new stopwatch methodology. Clin Pharmacol Ther 1996; 59: 130.

Packman

Leyva

Kellstein

Onset of analgesia with ibuprofen sodium in tension-type headache: a randomized trial. J Pharm Health Care Sci 2015; 1: 13.

Schachtel

Pan

Kohles

et al . Utility and sensitivity of the sore throat pain model: results of a randomized controlled trial on the COX-2 selective inhibitor valdecoxib. J Clin Pharmacol 2007; 47: 860–870.

Viscusi

Webster

Kuss

et al . A randomized, phase 2 study investigating TRV130, a biased ligand of the μ-opioid receptor, for the intravenous treatment of acute pain. Pain 2016; 157: 264–272.

Voelker

Schachtel

Cooper

et al . Efficacy of disintegrating aspirin in two different models for acute mild-to-moderate pain: sore throat pain and dental pain. Inflammopharmacology 2016; 24: 43–51.

Benrimoj

Langford

Christian

et al . Efficacy and tolerability of the anti-inflammatory throat lozenge flurbiprofen 8.75 mg in the treatment of sore throat: a randomised, double-blind, placebo-controlled study. Clin Drug Investig 2001; 21: 183–193.

Blagden

Christian

Miller

et al . Multidose flurbiprofen 8.75 mg lozenges in the treatment of sore throat: a randomised, double-blind, placebo-controlled study in UK general practice centres. Int J Clin Pract 2002; 56: 95–100.

Schachtel

Fillingim

Beiter

et al . Rating scales for analgesics in sore throat. Clin Pharmacol Ther 1984; 36: 151–156.

10.

Schachtel

BP.

Sore throat pain. In: Max

Portenoy

Laska

(eds) The design of analgesic clinical trials (Advances in pain research and therapy), vol. 18. New York: Raven Press, 1991, pp. 393–406.

11.

Schachtel

Fillingim

Lane

et al . Caffeine as an analgesic adjuvant. A double-blind study comparing aspirin with caffeine to aspirin and placebo in patients with sore throat. Arch Intern Med 1991; 151: 733–737.

12.

Schachtel

Homan

Gibb

et al . Demonstration of dose response of flurbiprofen lozenges with the sore throat pain model. Clin Pharmacol Ther 2002; 71: 375–380.

13.

Schachtel

Aspley

Shephard

et al . Onset of action of a lozenge containing flurbiprofen 8.75 mg: a randomized, double-blind, placebo-controlled trial with a new method for measuring onset of analgesic activity. Pain 2014; 155: 422–428.

14.

Schachtel

Aspley

Shephard

et al . Utility of the sore throat pain model in a multiple-dose assessment of the acute analgesic flurbiprofen: a randomized controlled study. Trials 2014; 15: 263.

15.

De Looze

Russo

Bloch

et al . Efficacy of flurbiprofen 8.75 mg spray in patients with sore throat due to an upper respiratory tract infection: a randomised controlled trial. Eur J Gen Pract 2016; 22: 111–118.

16.

Shephard

Reader

Hunt

A pilot study to evaluate the double stopwatch technique for determining onset of sore throat pain relief by a lozenge. Clin Ther 2017; 39(Suppl.8): e41.

17.

Schachtel

Fillingim

Lane

AC.

Demulcent action. Clin Pharmacol Ther 1984; 35: 373.

18.

Moore

Straube

Aldington

Pain measures and cut-offs – ‘no worse than mild pain’ as a simple, universal outcome. Anaesthesia 2013; 68: 400–412.

19.

Cepeda

Africano

Polo

et al . What decline in pain intensity is meaningful to patients with acute pain? Pain 2003; 105: 151–157.

20.

Schachtel

Aspley

Berry

et al . The ‘Definite Improvement Level’ (DIL) as a determinant of drug efficacy. J Pain 2013; 14: S5.

21.

Farrar

Young

LaMoreaux

et al . Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 2001; 94: 149–158.

22.

Farrar

Berlin

Strom

BL.

Clinically important changes in acute pain outcome measures: a validation study. J Pain Symptom Manage 2003; 25: 406–411.

23.

Shephard

Smith

Aspley

et al . Randomised, double-blind, placebo-controlled studies on flurbiprofen 8.75 mg lozenges in patients with/without group A or C streptococcal throat infection, with an assessment of clinicians’ prediction of ‘strep throat’. Int J Clin Pract 2015; 69: 59–71.

24.

Watson

Nimmo

Christian

et al . Relief of sore throat with the anti-inflammatory throat lozenge flurbiprofen 8.75 mg: a randomised, double-blind, placebo-controlled study of efficacy and safety. Int J Clin Pract 2000; 54: 490–496.

25.

Worrall

GJ.

Acute sore throat. Can Fam Physician 2007; 53: 1961–1962.

26.

Dekker

Verheij

van der Velden

AW.

Inappropriate antibiotic prescription for respiratory tract indications: most prominent in adult patients. Fam Pract 2015; 32: 401–407.

27.

Gulliford

Dregan

Moore

et al . Continued high rates of antibiotic prescribing to adults with respiratory tract infection: survey of 568 UK general practices. BMJ Open 2014; 4: e006245.

28.

Essack

Pignatari

AC.

A framework for the non-antibiotic management of upper respiratory tract infections: towards a global change in antibiotic resistance. Int J Clin Pract Suppl 2013; 67(180): 4–9.

29.

van der Velden

Bell

Sessa

et al . Sore throat: effective communication delivers improved diagnosis, enhanced self-care and more rational use of antibiotics. Int J Clin Pract Suppl 2013; 67(180): 10–16.

30.

Shulman

Bisno

Clegg

et al . Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America. Clin Infect Dis 2012; 55: 1279–1282.

31.

Pelucchi

Grigoryan

Galeone

et al . Guideline for the management of acute sore throat. Clin Microbiol Infect 2012; 18: 1–27.